EP4233850
HYLKJASAMSETNINGAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.11.2019EP published:
2.10.2024EP application number:
23160271.5
EP translation filed:
27.12.2024Grant published:
15.1.2025EPO information:
European Patent Register
Max expiry date:
26.11.2039Expiry date:
26.11.2026Next due date:
30.11.2026
Title in English:
CAPSULE FORMULATIONSLanguage of the patent:
English
Timeline
Today
27.11.2019EP application
2.10.2024EP Publication
27.12.2024Translation submitted
15.1.2025Registration published
26.11.2026Expires
Owner
Name:
ChemoCentryx, Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, US
Inventor
Name:
LELETI, Manmohan ReddyAddress:
California, 94568, US
Name:
POWERS, Jay PAddress:
California, 94044, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862773848 PDate:
30.11.2018Country:
US
Classification
Categories:
A61K 9/48, A61K 31/451, A61K 47/10, A61K 47/14, A61K 47/40, A61K 47/44, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 22.11.2024
Expires: 26.11.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 17.11.2025
Expires: 26.11.2026
Payer: Árnason Faktor ehf.